Translational Candidate

Injectable biomaterial derived from the natural scaffolding of pig hearts

Area of Impact

Improving the quality of life of patients with heart attacks

Mechanism of Action

The proposed mechanism of action is through recruitment of the body's own stem cells and reducing inflammation to heal the heart.

Unmet Medical Need

The prevalence of heart attacks is high yet there are not therapeutics that can adequately prevent heart failure.

Project Objective

Pre-IND meeting

Major Proposed Activities

• Manufacture product to support nonclinical studies required by FDA
• Nonclinical safety studies
• Clinical trial planning and development

The prevalence of heart attacks in CA is high in adults. The significant reduction in quality of life necessitates the development of new therapies for these patients. Our injectable biomaterial is a cost effective regenerative medicine strategy to improve cardiac function.